Author name: Vincent Racaniello

I'm Professor of Microbiology and Immunology at Columbia University in New York. I run a research lab where we study poliovirus, rhinovirus, and other RNA viruses. I also love teaching about viruses - check out virology.ws, microbe.tv, or iTunes University for some of my offerings. I want to be Earth's virology professor.

A better influenza virus animation

Earlier this year an influenza virus animation spread on YouTube just after the emergence of swine-origin influenza H1N1. I invited readers to criticise the animation which contained several errors. A much better depiction of influenza virus animation has been created by XVIVO. It’s not only more beautifully rendered, but is scientifically much more accurate. A …

A better influenza virus animation Read More »

TWiV 55: Mice lie, monkeys exaggerate

Hosts: Vincent Racaniello, Dick Despommier, Alan Dove, Jason Rodriguez, and Rich Condit In episode 55 of the podcast “This Week in Virology”, the largest TWiV panel ever assembled takes on XMRV and chronic fatigue syndrome, 2009 chemistry Nobel prizes for ribosome structure, finding new poxvirus vaccine candidates, a brouhaha over leaked Canadian data on influenza …

TWiV 55: Mice lie, monkeys exaggerate Read More »

XMRV not detected in German prostate cancer

Xenotropic murine leukemia virus-like virus (XMRV) was discovered in 2006 during a search for viral sequences in prostate cancer tissues. The results of a recent study revealed that the virus is present in 23% of prostate cancers from patients in the US. Understanding the role of XMRV in prostate cancers requires more extensive epidemiological studies, …

XMRV not detected in German prostate cancer Read More »

Influenza H1N1 vaccine approved in Canada

The influenza A (H1N1) 2009 vaccine produced by GlaxoSmithKline has been approved by Canada Health. Here is some information on the vaccine to supplement what I’ve provided about the US counterparts. The Canadian vaccine, called Arepanrix H1N1, is supplied in two parts. One contains inactivated H1N1 influenza virus, and the second consists of AS03 adjuvant …

Influenza H1N1 vaccine approved in Canada Read More »

Severe cases of pandemic influenza

The World Health Organization recently convened a meeting of 100 clinicians, scientists, and public health professionals to discuss the clinical features of pandemic influenza. They concluded that the vast majority of infections with the 2009 H1N1 influenza virus were uncomplicated and are followed by full recovery within 7 days. However, some patients, including children, develop …

Severe cases of pandemic influenza Read More »

Scroll to Top